Why the study?
Does sevoflurane compared to halothane prevent bradycardia and maintain heart rate following suxamethonium administration in healthy children?
Does sevoflurane compared to halothane prevent bradycardia and maintain heart rate following suxamethonium administration in healthy children?
Sevoflurane, unlike halothane, is associated with a significant increase in heart rate and no bradycardia following suxamethonium administration in children.
Answers are grounded in this paper and cite their sources.
Sevoflurane may reduce post-suxamethonium bradycardia risk versus halothane in children; leaves open whether this should alter practice pending randomized confirmation.
The changes in heart rate and arterial blood pressure following the administration of suxamethonium in healthy children (mean age 3.8±0.3 years) during inhalational induction with either sevoflurane (n=22) or halothane (n=19) were studied. Heart rate 60 s following suxamethonium administration increased significantly in the sevoflurane but not in the halothane group. In the halothane group, four children required intravenous (i.v.) atropine as a result of bradycardia. None of the children in the sevoflurane group developed bradycardia following suxamethonium (P<0.05). Values of oxygenation, ventilation and age corrected minimal alveolar concentration were comparable at all measurement times. The haemodynamic response to the administration of suxamethonium in children anaesthetized with sevoflurane seems to reflect the stimulation of the autonomic ganglia by suxamethonium whereas this positive chronotropic effect is attenuated or reversed by halothane.
No takes yet. Share an insight, caveat, or question.
Rieger et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: